Answer
Rivastigmine hydrogen tartrate can cause dizziness and sleepiness, mainly when starting treatment or increasing the dose, mildly or moderately affecting driving and machinery use, so the treating physician should routinely assess whether patients with dementia can continue driving or operating complex machinery.
Sources for this answer
- Rivastigmine Sandoz 1.5 mg hard capsules (Great Britain)Sandoz Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 10Document updated
Sources checked